Dr. Ransom is a graduate of the University of Iowa College of Medicine (1962) and was certified by the American Board of Allergy and Immunology in 1974. He is a Fellow of the American College of ...

If the symptoms persist beyond 12 weeks of treatment, the sinusitis is labeled as chronic. Bacterial growth on cultures obtained from the nose or nasopharynx, and growth on those obtained with ...

Six months after Amgen and AstraZeneca reported promising results for Tezspire (tezepelumab) as a potential treatment for ...

Expert says, that by recognising the connection between seasonal changes, allergies, and sinus health, individuals can take ...

AstraZeneca and Amgen's Phase 3 trial data shows Tezspire significantly reduces nasal polyps and congestion in patients with chronic rhinosinusitis with nasal polyps.

AstraZeneca and Amgen's drug could have a new use after positive Phase 3 study results. Elsewhere, Jazz set new plans for a ...

Have you ever been frustrated by one side of your nose feeling completely blocked while the other is clear? As annoying as it ...

Opioids have long been used to treat severe pain, though their use in the management of chronic pain remains somewhat controversial. Some people can tolerate opioids for years without any adverse ...

In July, she was informed that she was being dropped from a program that allowed her to get free infusions of a medication she needed to keep her chronic inflammatory bowel disease at bay.

Topline results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps and nasal congestion in adults with chronic rhinosinusitis with nasal polyps ...

(IN BRIEF) A Phase III trial of Tezspire (tezepelumab) by AstraZeneca and Amgen has shown significant benefits for patients ...

Dr Pirzada highlights "This inflammatory process can easily extend into the sinuses, leading to sinusitis and ... formation,” ...